Accepted for/Published in: JMIR Research Protocols
Date Submitted: Dec 19, 2022
Date Accepted: Jul 25, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
YouXin: A digital system to facilitate self-management in people with psychosis in China: protocol for a non-randomised validity and feasibility study with a mixed-methods design
ABSTRACT
Background:
Psychosis is one of the most disabling mental health conditions and causes significant personal, social and economic burdens. Accurate and timely symptom monitoring is critical in offering prompt and time sensitive clinical services. Digital health is a promising solution for the barriers encountered by conventional symptom monitoring approaches. However, there is no digital health technology developed to support self-management for people with psychosis in China.
Objective:
We report the study protocol to evaluate the validity, feasibility, acceptability, usability, and safety of a symptom self-monitoring smartphone app (YouXin; Chinese name 佑心) for people with psychosis in China.
Methods:
This is a non-randomised validity and feasibility study with a mixed-methods design. Participants with psychosis aged 16 to 65 years were recruited from Beijing Anding Hospital, Beijing, China. All participants were invited to use the YouXin app to self-monitor symptoms for 4 weeks. We invited participants to take part in a qualitative interview to explore acceptability of the app and trial procedures post-intervention.
Results:
The study was approved by the University of Manchester and Beijing Anding Hospital Research Ethics Committee. Recruitment to the study was initiated in August 2022. As of December 2022, 40 participants have completed the study, and the recruitment has been completed.
Conclusions:
This study is the first to develop and test a symptom self-monitoring app specifically designed for people with psychosis in China. The current study will inform the improvements in the app, trial procedures, and implementation strategies with this population. Moreover, the findings of this trial could lead to optimisation of Digital Health Technologies designed for people with psychosis in China.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.